FOR IMMEDIATE RELEASE: April 7, 2023
Contact: naf@berlinrosen.com
Today, Judge Matthew Kacsmaryk, a Trump-appointed federal judge in Texas ruled on a lawsuit filed by the far-right hate group Alliance Defending Freedom, and continued the FDA’s approval of mifepristone. The decision will not take effect for seven days to give the government time to appeal.
Statement from Melissa Fowler, Chief Program Officer at the National Abortion Federation:
Today’s reign is appalling, though not at all surprising to any of us in the fight for reproductive freedom. It’s a painful reminder that anti-abortion extremists will stop at nothing to take away our right to life-saving abortion care, including sowing chaos and confusion for abortion seekers.
Let’s be clear: This decision has nothing to do with the efficacy and safety of mifepristone, which has been well established for decades. The goal of anti-abortion opponents is to block access to abortion by prohibiting care or making it difficult and difficult for patients to seek care where abortion remains legal. We will not let that happen. We are working in advance of this decision to ensure that our national network of member providers can continue to provide compassionate, clinically efficient, evidence-based care to patients. At the same time, the NAF Hotline will continue to provide abortion seekers with the accurate information, resources, and support they need to access the abortion care they deserve.
Despite this decision, the abortion drug is still available. If you need information about your options, you can call the National Abortion Hotline: 1-800-772-9100.
